Abstract
We conducted a second nationwide severe acute respiratory syndrome coronavirus 2 seroprevalence study in the Faroe Islands during November 2020. We found crude seroprevalence was 0.3% and prevalence was 0.4% after adjusting for test sensitivity and specificity. This low seroprevalence supports the prevention strategies used in the Faroe Islands.
| Original language | English |
|---|---|
| Pages (from-to) | 242-244 |
| Number of pages | 3 |
| Journal | Emerging Infectious Diseases |
| Volume | 28 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Jan 2022 |
Keywords
- COVID-19
- Faroe Islands
- SARS
- SARS-CoV-2
- coronavirus
- coronavirus disease
- respiratory infections
- seroprevalence
- severe acute respiratory syndrome coronavirus 2
- viruses
- zoonoses